Mechanism of Hyperkalemia-Induced Metabolic Acidosis. Harris AN, Grimm PR, Lee HW, Delpire E, Fang L, Verlander JW, Welling PA, Weiner ID (2018) J Am Soc Nephrol 29: 1411-1425 Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. Gangadhariah MH, Luther JM, Garcia V, Paueksakon P, Zhang MZ, Hayward SW, Love HD, Falck JR, Manthati VL, Imig JD, Schwartzman ML, Zent R, Capdevila JH, Pozzi A (2015) J Am Soc Nephrol 26: 597-610 Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules. Grimm PR, Coleman R, Delpire E, Welling PA (2017) J Am Soc Nephrol 28: 2597-2606 Effects of antihypertensive drugs on glomerular morphology. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I (1989) Kidney Int 36: 626-35 ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time. Brown NJ, Kumar S, Painter CA, Vaughan DE (2002) Hypertension 40: 859-65 Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ (2005) Hypertension 46: 313-20 Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. Sawathiparnich P, Kumar S, Vaughan DE, Brown NJ (2002) J Clin Endocrinol Metab 87: 448-52 Antihypertensive effects of low doses of hydrochlorothiazide in hypertensive black Zimbabweans. Stein CM, Neill P, Kusemamuriwo T (1992) Int J Cardiol 37: 231-5 Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe. Stein CM, Neill P, Mwaluko GM, Kusema T (1990) S Afr Med J 77: 243-5
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.